| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 2e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.24 | 4e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |